J N Zuckerman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J N Zuckerman

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Tissue Antigens|July 1, 1997

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccinationA B McDermott, J N Zuckerman, C A Sabin, et al.

Vaccine|January 23, 2002

A new accelerated vaccination schedule for rapid protection against hepatitis A and BH D Nothdurft, M Dietrich, J N Zuckerman, et al.

Hepatology (Baltimore, Md.)|October 5, 2001

Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccinesJ N Zuckerman, A J Zuckerman, I Symington, et al.

Vaccine|November 9, 2004

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04G Boland, J Beran, M Lievens, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Tissue Antigens|July 1, 1997

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccinationA B McDermott, J N Zuckerman, C A Sabin, et al.

Vaccine|January 23, 2002

A new accelerated vaccination schedule for rapid protection against hepatitis A and BH D Nothdurft, M Dietrich, J N Zuckerman, et al.

Hepatology (Baltimore, Md.)|October 5, 2001

Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccinesJ N Zuckerman, A J Zuckerman, I Symington, et al.

Vaccine|November 9, 2004

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04G Boland, J Beran, M Lievens, et al.

Pageof 4